Professor
The University of Texas MD Anderson Cancer Center
Houston, TX, United States
Dr. Lai is a tenured Professor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center and a board-certified head and neck cancer surgeon. Dr. Lai has joint appointments in the Department of Molecular and Cellular Oncology and the Department of Radiation Oncology. Dr. Lai received his undergraduate degree from Stanford University and his medical and doctorate degrees from The University of California, San Francisco. He performed his residency at The University of Pennsylvania and completed his fellowship in oncologic head and neck/cranial base surgery at The University of Pittsburgh School of Medicine. His clinical expertise is in head and neck cancers with a special emphasis on oral cavity cancer, thyroid and parathyroid disease, salivary gland neoplasms, and conservation laryngeal surgery. Dr. Lai takes a multidisciplinary approach to the management of head and neck cancer patients with a committed engagement to cutting-edge treatment protocols. He is the principal investigator for the NRG Oncology international randomized prospective clinical trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer (NRG-HN006; NCT04333537). Dr. Lai has robust basic and translational research program focused on novel therapies for head and neck squamous cell carcinoma (HNSCC) and anaplastic thyroid cancer (ATC), as well as development of imaging technologies to assess tumor metabolism and normal tissue toxicity. Dr. Lai has received research awards from the National Cancer Institute (NCI), National Institute of Dental and Craniofacial Research (NIDCR), American College of Surgeons, American Head and Neck Society (AHNS), American Academy of Otolaryngology - Head and Neck Surgery Foundation, The Thyroid Head and Neck Cancer (THANC) Foundation and the Cancer Prevention Research Institute of Texas. Dr. Lai holds national leadership positions as Research Division Chair for AHNS and Chair of the Surgical Oncology Committee for NRG Oncology.
Sentinel Node Biopsy for Oral Cavity Cancer: Establishing the Workflow
Sunday, September 29, 2024
4:00 PM – 5:00 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.